<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Family Medicine Publications</title>
<copyright>Copyright (c) 2013 Western University All rights reserved.</copyright>
<link>http://ir.lib.uwo.ca/fammedpub</link>
<description>Recent documents in Family Medicine Publications</description>
<language>en-us</language>
<lastBuildDate>Sun, 27 Jan 2013 00:09:09 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Challenges to the Provision of Diabetes Care in First Nations Communities: Results from a National Survey of Healthcare Providers in Canada</title>
<link>http://ir.lib.uwo.ca/fammedpub/14</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/14</guid>
<pubDate>Fri, 25 Nov 2011 18:36:21 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Aboriginal peoples globally, and First Nations peoples in Canada particularly, suffer from high rates of type 2 diabetes and related complications compared with the general population. Research into the unique barriers faced by healthcare providers working in on-reserve First Nations communities is essential for developing effective quality improvement strategies.</p>
<p>METHODS: In Phase I of this two-phased study, semi-structured interviews and focus groups were held with 24 healthcare providers in the Sioux Lookout Zone in north-western Ontario. A follow-up survey was conducted in Phase II as part of a larger project, the Canadian First Nations Diabetes Clinical Management and Epidemiologic (CIRCLE) study. The survey was completed with 244 healthcare providers in 19 First Nations communities in 7 Canadian provinces, representing three isolation levels (isolated, semi-isolated, non-isolated). Interviews, focus groups and survey questions all related to barriers to providing optimal diabetes care in First Nations communities.</p>
<p>RESULTS: the key factors emerging from interviews and focus group discussions were at the patient, provider, and systemic level. Survey results indicated that, across three isolation levels, healthcare providers' perceived patient factors as having the largest impact on diabetes care. However, physicians and nurses were more likely to rank patient factors as having a large impact on care than community health representatives (CHRs) and physicians were significantly less likely to rank patient-provider communication as having a large impact than CHRs.</p>
<p>CONCLUSIONS: Addressing patient factors was considered the highest impact strategy for improving diabetes care. While this may reflect "patient blaming," it also suggests that self-management strategies may be well-suited for this context. Program planning should focus on training programs for CHRs, who provide a unique link between patients and clinical services. Research incorporating patient perspectives is needed to complete this picture and inform quality improvement initiatives.</p>

	]]>
</description>

<author>Onil K. Bhattacharyya et al.</author>


</item>






<item>
<title>Effective Interventions to Facilitate the Uptake of Breast, Cervical and Colorectal Cancer Screening: An Implementation Guideline</title>
<link>http://ir.lib.uwo.ca/fammedpub/13</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/13</guid>
<pubDate>Fri, 25 Nov 2011 18:16:38 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Appropriate screening may reduce the mortality and morbidity of colorectal, breast, and cervical cancers. Several high-quality systematic reviews and practice guidelines exist to inform the most effective screening options. However, effective implementation strategies are warranted if the full benefits of screening are to be realized. We developed an implementation guideline to answer the question: What interventions have been shown to increase the uptake of cancer screening by individuals, specifically for breast, cervical, and colorectal cancers?</p>
<p>METHODS: A guideline panel was established as part of Cancer Care Ontario's Program in Evidence-based Care, and a systematic review of the published literature was conducted. It yielded three foundational systematic reviews and an existing guidance document. We conducted updates of these reviews and searched the literature published between 2004 and 2010. A draft guideline was written that went through two rounds of review. Revisions were made resulting in a final set of guideline recommendations.</p>
<p>RESULTS: Sixty-six new studies reflecting 74 comparisons met eligibility criteria. They were generally of poor to moderate quality. Using these and the foundational documents, the panel developed a draft guideline. The draft report was well received in the two rounds of review with mean quality scores above four (on a five-point scale) for each of the items. For most of the interventions considered, there was insufficient evidence to support or refute their effectiveness. However, client reminders, reduction of structural barriers, and provision of provider assessment and feedback were recommended interventions to increase screening for at least two of three cancer sites studied. The final guidelines also provide advice on how the recommendations can be used and future areas for research.</p>
<p>CONCLUSION: Using established guideline development methodologies and the AGREE II as our methodological frameworks, we developed an implementation guideline to advise on interventions to increase the rate of breast, cervical and colorectal cancer screening. While advancements have been made in these areas of implementation science, more investigations are warranted.</p>

	]]>
</description>

<author>Melissa C. Brouwers et al.</author>


</item>






<item>
<title>What Implementation Interventions Increase Cancer Screening Rates? A Systematic Review</title>
<link>http://ir.lib.uwo.ca/fammedpub/12</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/12</guid>
<pubDate>Sun, 30 Oct 2011 19:45:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Appropriate screening may reduce the mortality and morbidity of colorectal, breast, and cervical cancers. However, effective implementation strategies are warranted if the full benefits of screening are to be realized. As part of a larger agenda to create an implementation guideline, we conducted a systematic review to evaluate interventions designed to increase the rate of breast, cervical, and colorectal cancer (CRC) screening. The interventions considered were: client reminders, client incentives, mass media, small media, group education, one-on-one education, reduction in structural barriers, reduction in out-of-pocket costs, provider assessment and feedback interventions, and provider incentives. Our primary outcome, screening completion, was calculated as the overall median post-intervention absolute percentage point (PP) change in completed screening tests.</p>
<p>METHODS: Our first step was to conduct an iterative scoping review in the research area. This yielded three relevant high-quality systematic reviews. Serving as our evidentiary foundation, we conducted a formal update. Randomized controlled trials and cluster randomized controlled trials, published between 2004 and 2010, were searched in MEDLINE, EMBASE and PSYCHinfo.</p>
<p>RESULTS: The update yielded 66 studies new eligible studies with 74 comparisons. The new studies ranged considerably in quality. Client reminders, small media, and provider audit and feedback appear to be effective interventions to increase the uptake of screening for three cancers. One-on-one education and reduction of structural barriers also appears effective, but their roles with CRC and cervical screening, respectively, are less established. More study is required to assess client incentives, mass media, group education, reduction of out-of-pocket costs, and provider incentive interventions.</p>
<p>CONCLUSION: The new evidence generally aligns with the evidence and conclusions from the original systematic reviews. This review served as the evidentiary foundation for an implementation guideline. Poor reporting, lack of precision and consistency in defining operational elements, and insufficient consideration of context and differences among populations are areas for additional research.</p>

	]]>
</description>

<author>Melissa C. Brouwers et al.</author>


</item>






<item>
<title>Assessing the Outcomes of Participatory Research: Protocol for Identifying, Selecting, Appraising and Synthesizing the Literature for Realist Review</title>
<link>http://ir.lib.uwo.ca/fammedpub/11</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/11</guid>
<pubDate>Tue, 19 Apr 2011 17:08:11 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Participatory Research (PR) entails the co-governance of research by academic researchers and end-users. End-users are those who are affected by issues under study (e.g., community groups or populations affected by illness), or those positioned to act on the knowledge generated by research (e.g., clinicians, community leaders, health managers, patients, and policy makers). Systematic reviews assessing the generalizable benefits of PR must address: the diversity of research topics, methods, and intervention designs that involve a PR approach; varying degrees of end-user involvement in research co-governance, both within and between projects; and the complexity of outcomes arising from long-term partnerships.</p>
<p>METHODS: We addressed the above mentioned challenges by adapting realist review methodology to PR assessment, specifically by developing inductively-driven identification, selection, appraisal, and synthesis procedures. This approach allowed us to address the non-uniformity and complexity of the PR literature. Each stage of the review involved two independent reviewers and followed a reproducible, systematic coding and retention procedure. Retained studies were completed participatory health interventions, demonstrated high levels of participation by non-academic stakeholders (i.e., excluding studies in which end-users were not involved in co-governing throughout the stages of research) and contained detailed descriptions of the participatory process and context. Retained sets are being mapped and analyzed using realist review methods.</p>
<p>RESULTS: The librarian-guided search string yielded 7,167 citations. A total of 594 citations were retained after the identification process. Eighty-three papers remained after selection. Principle Investigators (PIs) were contacted to solicit all companion papers. Twenty-three sets of papers (23 PR studies), comprising 276 publications, passed appraisal and are being synthesized using realist review methods.</p>
<p>DISCUSSION: The systematic and stage-based procedure addressed challenges to PR assessment and generated our robust understanding of complex and heterogeneous PR practices. To date, realist reviews have focussed on evaluations of relatively uniform interventions. In contrast our PR search yielded a wide diversity of partnerships and research topics. We therefore developed tools to achieve conceptual clarity on the PR field, as a beneficial precursor to our theoretically-driven synthesis using realist methods. Findings from the ongoing review will be provided in forthcoming publications.</p>

	]]>
</description>

<author>Justin Jagosh et al.</author>


</item>






<item>
<title>Efficacy of a Family Practice-based Lifestyle Intervention Program to Increase Physical Activity and Reduce Clinical and Physiological Markers of Vascular Health in Patients with High Normal Blood Pressure and/or High Normal Blood Glucose (SNAC): Study Protocol for a Randomized Controlled Trial</title>
<link>http://ir.lib.uwo.ca/fammedpub/10</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/10</guid>
<pubDate>Tue, 19 Apr 2011 16:31:23 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Previous interventions to increase physical activity and reduce cardiovascular risk factors have been targeted at individuals with established disease; less attention has been given to intervention among individuals with high risk for disease nor has there been determination of the influence of setting in which the intervention is provided. In particular, family practice represents an ideal setting for the provision and long-term maintenance of lifestyle interventions for patients at risk (ie high-normal blood pressure or impaired glucose tolerance).</p>
<p>METHODS/DESIGN: The Staged Nutrition and Activity Counseling (SNAC) study is a randomized clustered design clinical trial that will investigate the effectiveness and efficacy of a multi-component lifestyle intervention on cardiovascular disease risk factors and vascular function in patients at risk in primary care. Patients will be randomized by practice to either a standard of care lifestyle intervention or a behaviourally-based, matched prescriptive physical activity and diet change program. The primary goal is to increase physical activity and improve dietary intake according to Canada's Guides to Physical Activity Healthy Eating over 24 months. The primary intention to treat analysis will compare behavioral, physiological and metabolic outcomes at 6, 12 and 24 months post-randomization including estimation of incident hypertension and/or diabetes.</p>
<p>DISCUSSION: The design features of our trial, and the practical problems (and solutions) associated with implementing these design features, particularly those that result in potential delay between recruitment, baseline data collection, randomization, intervention, and assessment will be discussed. Results of the SNAC trial will provide scientific rationale for the implementation of this lifestyle intervention in primary care.</p>
<p>TRIAL REGISTRATION: ISRCTN: ISRCTN:42921300.</p>

	]]>
</description>

<author>Robert J. Petrella et al.</author>


</item>






<item>
<title>Investigating Concordance in Diabetes Diagnosis between Primary Care Charts (Electronic Medical Records) and Health Administrative Data: A Retrospective Cohort Study</title>
<link>http://ir.lib.uwo.ca/fammedpub/9</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/9</guid>
<pubDate>Mon, 14 Mar 2011 17:33:54 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Electronic medical records contain valuable clinical information not readily available elsewhere. Accordingly, they hold important potential for contributing to and enhancing chronic disease registries with the goal of improving chronic disease management; however a standard for diagnoses of conditions such as diabetes remains to be developed. The purpose of this study was to establish a validated electronic medical record definition for diabetes.</p>
<p>METHODS: We constructed a retrospective cohort using health administrative data from the Institute for Clinical Evaluative Sciences Ontario Diabetes Database linked with electronic medical records from the Deliver Primary Healthcare Information Project using data from 1 April 2006-31 March 2008 (N = 19,443). We systematically examined eight definitions for diabetes diagnosis, both established and proposed.</p>
<p>RESULTS: The definition that identified the highest number of patients with diabetes (N = 2,180) while limiting to those with the highest probability of having diabetes was: individuals with ≥2 abnormal plasma glucose tests, or diabetes on the problem list, or insulin prescription, or ≥2 oral anti-diabetic agents, or HbA1c ≥6.5%. Compared to the Ontario Diabetes Database, this definition identified 13% more patients while maintaining good sensitivity (75%) and specificity (98%).</p>
<p>CONCLUSIONS: This study establishes the feasibility of developing an electronic medical record standard definition of diabetes and validates an algorithm for use in this context. While the algorithm may need to be tailored to fit available data in different electronic medical records, it contributes to the establishment of validated disease registries with the goal of enhancing research, and enabling quality improvement in clinical care and patient self-management.</p>

	]]>
</description>

<author>Stewart B. Harris et al.</author>


</item>






<item>
<title>Canadian Global Village Reality: Anthropometric Surrogate Cutoffs and Metabolic Abnormalities among Canadians of East Asian, South Asian, and European Descent</title>
<link>http://ir.lib.uwo.ca/fammedpub/8</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/8</guid>
<pubDate>Sun, 20 Jun 2010 17:42:08 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: To test the appropriateness of body mass index (BMI) and waist circumference (WC) cutoff points derived in largely white populations (ie, those of European descent) for detecting obesity-related metabolic abnormalities among East Asian and South Asian Canadians.</p>
<p>DESIGN: Cross-sectional survey.</p>
<p>SETTING: Primary care and community settings in Ontario.</p>
<p>PARTICIPANTS: Canadians of East Asian (n = 130), South Asian (n = 113), and European (n = 111) descent.</p>
<p>MAIN OUTCOME MEASURES: Variables for metabolic syndromes, including BMI, WC, body fat percentage, blood pressure, lipid profile, and fasting blood glucose and insulin levels, were measured. Receiver operating characteristics curve analysis was used to generate BMI and WC cutoff points based on various criteria for metabolic syndromes.</p>
<p>RESULTS: Adjusting for sex and age, East Asian Canadians had a significantly lower mean BMI (23.2 kg/m(2)) and mean WC (79.6 cm) than did those of South Asian (26.1 kg/m(2) and 90.3 cm) and European (26.5 kg/m(2) and 89.3 cm) descent (P < .05). The BMI cutoffs for an increased risk of metabolic abnormalities ranged from 23.1 to 24.4 kg/m(2) in East Asian Canadians; 26.6 to 26.8 kg/m(2) in South Asian Canadians; and 26.3 to 28.2 kg/m(2) in European Canadians. Waist circumference cutoffs for increased risk of metabolic abnormalities were relatively low in East Asian men (83.3 to 85.2 cm) and women (74.1 to 76.7 cm), compared with South Asian men (98.8 cm) and women (90.1 to 93.5 cm), as well as European men (91.6 to 95.2 cm) and women (82.8 to 88.3 cm).</p>
<p>CONCLUSION: The BMI and WC cutoffs used for defining risk of metabolic abnormalities should be lowered for East Asian Canadians but not for South Asian Canadians. The World Health Organization ethnic-specific BMI and WC cutoffs should be used with caution, particularly with Asian migrants who have resided in Canada for a long period of time.</p>

	]]>
</description>

<author>Meizi He et al.</author>


</item>






<item>
<title>Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population</title>
<link>http://ir.lib.uwo.ca/fammedpub/7</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/7</guid>
<pubDate>Sun, 04 Apr 2010 23:16:30 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Expanding evidence indicates that apolipoprotein B (apo B) is superior to LDL cholesterol as a marker of vascular disease. Although traditional lipid measures are known to predict type 2 diabetes, limited data are available regarding apo B. We assessed the association of apo B with incident type 2 diabetes and compared it with traditional lipid variables as a risk predictor in aboriginal Canadians.</p>
<p>METHODS: Of an initial cohort of 606 individuals without diabetes in 1993-1995, 540 were contacted for the 10-year follow-up evaluation in 2003-2005. Fasting and 2-h postload glucose concentrations were obtained at baseline and follow-up to determine incident type 2 diabetes. Baseline fasting serum lipids were measured with standard laboratory procedures.</p>
<p>RESULTS: The cumulative 10-year incidence of type 2 diabetes was 17.5%. High concentrations of apo B, triglycerides, and LDL cholesterol, and low concentrations of HDL cholesterol were individually associated with incident type 2 diabetes in univariate analyses. Comparing C statistics of univariate models showed apo B to be a superior determinant of incident diabetes compared with LDL (P = 0.026) or HDL (P = 0.004) cholesterol. With multivariate adjustment including waist circumference, apo B (odds ratio, 1.50; 95% CI, 1.11-2.02) and triglycerides (odds ratio, 1.49; 95% CI, 1.12-1.98) remained associated with incident diabetes, whereas LDL and HDL cholesterol became nonsignificant.</p>
<p>CONCLUSIONS: The association of plasma apo B with incident type 2 diabetes and its better prediction of risk compared with LDL or HDL cholesterol suggest the potential for the use of apo B in type 2 diabetes risk communication and prevention.</p>

	]]>
</description>

<author>Sylvia H. Ley et al.</author>


</item>






<item>
<title>Predictors of Motor Vehicle Collision Injuries Among a Nationally Representative Sample of Canadians</title>
<link>http://ir.lib.uwo.ca/fammedpub/6</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/6</guid>
<pubDate>Thu, 24 Dec 2009 17:14:58 PST</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: The purpose of this study was to examine predictors of subsequent motor vehicle collision injuries, with a particular focus on health-related variables, using the longitudinal dataset from the Canadian National Population Health Survey (NPHS) for the years 1994-2002.</p>
<p>METHODS: Multiple logistic regression analysis was used to determine the relations between motor vehicle collision injury and four risk factors: binge drinking, health status, distress, and medication use. Age and sex were included as control variables. The total sample size was 14,529.</p>
<p>RESULTS: A higher percentage of females and younger persons reported a motor vehicle collision injury. Binge drinkers, respondents with poor health, respondents with distress, and respondents reported using two or more medications reported a higher percentage of subsequent injuries. Logistic regression analysis found that persons with poorer health status and persons who used more medications had higher odds of motor vehicle injuries. Only one statistically significant interaction effect was found: alcohol bingeing and medication use.</p>
<p>CONCLUSIONS: Among a nationally representative sample of Canadians, various demographic and risk factors predict subsequent injuries. Given that this number represents a considerable economic burden, this study underscores the need for continued research and countermeasures on alcohol, drugs, and driving.</p>

	]]>
</description>

<author>Evelyn Vingilis et al.</author>


<category>Accidents, Traffic</category>

<category>Adolescent</category>

<category>Adult</category>

<category>Aged</category>

<category>Alcoholism</category>

<category>Automobile Driving</category>

<category>Canada</category>

<category>Female</category>

<category>Health Status</category>

<category>Health Surveys</category>

<category>Humans</category>

<category>Longitudinal Studies</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Odds Ratio</category>

<category>Retrospective Studies</category>

<category>Risk Factors</category>

<category>Sex Factors</category>

<category>Substance-Related Disorders</category>

<category>Wounds and Injuries</category>

</item>






<item>
<title>Choosing Family Medicine.  What Influences Medical Students?</title>
<link>http://ir.lib.uwo.ca/fammedpub/5</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/5</guid>
<pubDate>Mon, 21 Dec 2009 10:27:03 PST</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: To explore factors that influence senior medical students to pursue careers in family medicine.</p>
<p>DESIGN: Qualitative study using semistructured interviews.</p>
<p>SETTING: University of Western Ontario (UWO) in London.</p>
<p>PARTICIPANTS: Eleven of 29 graduating UWO medical students matched to Canadian family medicine residency programs beginning in July 2001.</p>
<p>METHOD: Eleven semistructured interviews were conducted with a maximum variation sample of medical students. Interviews were transcribed and reviewed independently, and a constant comparative approach was used by the team to analyze the data.</p>
<p>MAIN FINDINGS: Family physician mentors were an important influence on participants' decisions to pursue careers in family medicine. Participants followed one of three pathways to selecting family medicine: from an early decision to pursue family medicine, from initial uncertainty about career choice, or from an early decision to specialize and a change of mind.</p>
<p>CONCLUSION: The perception of a wide scope of practice attracts candidates to family medicine. Having more family medicine role models early in medical school might encourage more medical students to select careers in family medicine.</p>

	]]>
</description>

<author>John Jordan et al.</author>


<category>Adult</category>

<category>Decision Making</category>

<category>Education, Medical</category>

<category>Family Practice</category>

<category>Female</category>

<category>Humans</category>

<category>Interviews as Topic</category>

<category>Male</category>

<category>Mentors</category>

<category>Ontario</category>

<category>Students, Medical</category>

</item>






<item>
<title>Metabolic Syndrome and Its Components as Predictors of Incident Type 2 Diabetes Mellitus in an Aboriginal Community</title>
<link>http://ir.lib.uwo.ca/fammedpub/4</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/4</guid>
<pubDate>Fri, 18 Dec 2009 22:54:36 PST</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Risk factors for type 2 diabetes remain poorly characterized among Aboriginal Canadians. We aimed to determine the incidence of type 2 diabetes in an Aboriginal community and to evaluate prospective associations with metabolic syndrome and its components.</p>
<p>METHODS: Of 606 participants in the Sandy Lake Health and Diabetes Project from 1993 to 1995 who were free of diabetes at baseline, 540 (89.1%) participated in 10-year follow-up assessments. Baseline anthropometry, blood pressure, fasting insulin and serum lipid levels were measured. Fasting and 2-hour postload glucose levels were obtained at follow-up to determine incident cases of type 2 diabetes.</p>
<p>RESULTS: The 10-year cumulative incidence of diabetes was 17.5%. High adiposity, dyslipidemia, hyperglycemia, hyperinsulinemia and hypertension at baseline were associated with an increased risk of diabetes after adjustment for age and sex (all p < or = 0.03). Metabolic syndrome had high specificity (75%-88%) and high negative predictive value (85%-87%) to correctly detect diabetes-free individuals at follow-up. It had low sensitivity (26%-48%) and low positive predictive value (29%-32%) to detect future diabetes. Metabolic syndrome at baseline was associated with incident diabetes after adjustment for age and sex, regardless of whether the syndrome was defined using the National Cholesterol Education Program criteria (odds ratio [OR] 2.03, 95% confidence interval [CI] 1.10-3.75) or the International Diabetes Federation criteria (OR 2.14, 95% CI 1.29-3.55). The association was to the same degree as that for impaired glucose tolerance assessed using the oral glucose tolerance test (OR 2.87, 95% CI 1.52-5.40; p > 0.05 for comparison of C statistics).</p>
<p>INTERPRETATION: Metabolic syndrome and its components can be identified with readily available clinical measures. As such, the syndrome may be useful for identifying individuals at risk of type 2 diabetes in remote Aboriginal communities.</p>

	]]>
</description>

<author>Sylvia H. Ley et al.</author>


<category>Adolescent</category>

<category>Adult</category>

<category>Age Distribution</category>

<category>Blood Glucose</category>

<category>Body Fat Distribution</category>

<category>Body Height</category>

<category>Body Mass Index</category>

<category>Canada</category>

<category>Child</category>

<category>Diabetes Mellitus, Type 2</category>

<category>Dyslipidemias</category>

<category>Fasting</category>

<category>Female</category>

<category>Follow-Up Studies</category>

<category>Humans</category>

<category>Hyperglycemia</category>

<category>Hypertension</category>

<category>Incidence</category>

<category>Logistic Models</category>

<category>Male</category>

<category>Metabolic Syndrome X</category>

<category>Middle Aged</category>

<category>Predictive Value of Tests</category>

<category>Prospective Studies</category>

<category>Risk Factors</category>

<category>Sensitivity and Specificity</category>

<category>Sex Factors</category>

<category>Waist Circumference</category>

<category>Young Adult</category>

</item>






<item>
<title>Association of the Novel Cardiovascular Risk Factors Paraoxonase 1 and Cystatin C in Type 2 Diabetes</title>
<link>http://ir.lib.uwo.ca/fammedpub/3</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/3</guid>
<pubDate>Sun, 06 Dec 2009 19:31:34 PST</pubDate>
<description>
	<![CDATA[
	<p>Paraoxonase 1 (PON1) has been reported to be associated with proteinuria in subjects with type 2 diabetes mellitus (T2DM). Plasma cystatin C is more accurate than creatinine for identifying stage 3 kidney disease in T2DM. We tested the hypothesis that PON1 and cystatin C would be associated in T2DM subjects from an Aboriginal Canadian community, who are at high risk for the development of nephropathy. PON1 A(-162)G and PON2 Ala148Gly genotypes, cystatin C, HbA1c, high density lipoprotein cholesterol (HDLC), waist circumference (waist), and duration of diabetes were included in the regression analysis with log(e) (ln) of PON1 mass as the dependent variable. A regression model including PON2 Ala148Gly genotype, HDLC, and ln cystatin C explained 25.8% of the variance in PON1 mass. Conversely, waist, age, ln HbA1c, ln duration of diabetes, and ln PON1 mass, but not PON2 genotype, explained 38% of the variance in cystatin C. Subjects with cystatin C estimated glomerular filtration rate (eGFR) <60 ml>/min per 1.73 m(2) (stage 3 kidney disease) had significantly lower PON1 mass compared with subjects with cystatin C-eGFR >60 ml/min per 1.73 m(2). The lower mass of PON1, an anti-inflammatory HDL-associated enzyme, in T2DM with cystatin C-eGFR <60 ml>/min per 1.73 m(2) may contribute to their increased risk for cardiovascular disease.</p>

	]]>
</description>

<author>Philip W. Connelly et al.</author>


<category>Adult</category>

<category>Aryldialkylphosphatase</category>

<category>Canada</category>

<category>Cardiovascular Diseases</category>

<category>Cystatin C</category>

<category>Diabetes Complications</category>

<category>Diabetes Mellitus, Type 2</category>

<category>Female</category>

<category>Genetic Predisposition to Disease</category>

<category>Genotype</category>

<category>Glomerular Filtration Rate</category>

<category>Humans</category>

<category>Indians, North American</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Models, Biological</category>

<category>Polymorphism, Genetic</category>

<category>Regression Analysis</category>

<category>Risk Factors</category>

</item>






<item>
<title>Do Patients Receive Recommended Treatment of Osteoporosis Following Hip Fracture in Primary Care?</title>
<link>http://ir.lib.uwo.ca/fammedpub/2</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/2</guid>
<pubDate>Wed, 23 Sep 2009 15:46:42 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: Osteoporosis results in fractures and treatment of osteoporosis has been shown to reduce risk of fracture particularly in those who have had a history of fracture.</p>
<p>Methods: A prospective study was conducted using patients admitted to a hip fracture rehabilitation program at a large referral center to evaluate the use of treatments recommended for secondary prevention of osteoporotic fracture between September 1, 2001 and September 30, 2003. The frequency of medication use for the treatment of osteoporosis including estrogen replacement therapy, bisphosponates, calcitonin, calcium and vitamin D therapy was determined on admission, at 6 weeks post discharge and one year following discharge. All patients were discharged to the care of their family physician. All family physicians in the referral region received a copy of the Canadian Consensus recommendations for osteoporosis management 1-3 months prior to the study.</p>
<p>Results: During the study period, 174 patients were enrolled and 121 completed all assessments. Fifty-seven family physicians were identified as caring for 1 or more of the study patients. Only 7 patients had previous BMD, only 5 patients had previously been prescribed a bisphosponate and 14 patients were taking calcium and/or vitamin D. All patients were prescribed 2500 mg calcium, 400 IU vitamin D and 5 mg residronate daily during rehabilitation and at discharge.Following discharge, a significant improvement was seen in all clinical indices of functional mobility, including the functional independence measure (FIM), walking distance, fear of falling score (FFS), and the Berg balance score (BBS). At six weeks a significant (p < 0.01) decrease in calcium and vitamin D use was observed. All patients remained compliant with residronate therapy. At twelve months 71 patients remained on residronate (p < 0.01), 10 were now taking alternate bisphosphonate therapy and few were taking calcium and/or vitamin D (p < 0.001). FIM, FFS and Berg scores were significantly decreased from discharge (p < 0.001) while walking distance was unchanged.</p>
<p>Conclusion: Few patients admitted for hip fracture had previously taken recommended osteoporosis therapy including bisphosphonates. While compliance with Canadian Consensus recommendations was observed at six weeks, this was not the case at twelve months post hip fracture rehabilitation. Interventions to improve not only the detection and treatment of osteoporosis but also the ongoing treatment and management post-fracture need to be developed and implemented.</p>

	]]>
</description>

<author>Robert J. Petrella et al.</author>


<category>Aftercare</category>

<category>Aged</category>

<category>Aged, 80 and over</category>

<category>Bone Density Conservation Agents</category>

<category>Calcitonin</category>

<category>Calcium</category>

<category>Dietary Supplements</category>

<category>Diphosphonates</category>

<category>Drug Utilization</category>

<category>Estrogen Replacement Therapy</category>

<category>Family Practice</category>

<category>Female</category>

<category>Guideline Adherence</category>

<category>Hip Fractures</category>

<category>Humans</category>

<category>Male</category>

<category>Ontario</category>

<category>Osteoporosis</category>

<category>Primary Health Care</category>

<category>Rehabilitation Centers</category>

<category>Treatment Outcome</category>

<category>Vitamin D</category>

</item>






<item>
<title>EXACKTE2: Exploiting the Clinical Consultation as a Knowledge Transfer and Exchange Environment: A Study Protocol</title>
<link>http://ir.lib.uwo.ca/fammedpub/1</link>
<guid isPermaLink="true">http://ir.lib.uwo.ca/fammedpub/1</guid>
<pubDate>Thu, 14 May 2009 15:20:36 PDT</pubDate>
<description>
	<![CDATA[
	<p>Background: While the evidence suggests that the way physicians provide information to patients is crucial in helping patients decide upon a course of action, the field of knowledge translation and exchange (KTE) is silent about how the physician and the patient influence each other during clinical interactions and decision-making. Consequently, based on a novel relationshipcentered model, EXACKTE2 (EXploiting the clinicAl Consultation as a Knowledge Transfer and Exchange Environment), this study proposes to assess how patients and physicians influence each other in consultations.</p>
<p>Methods: We will employ a cross-sectional study design involving 300 pairs of patients and family physicians from two primary care practice-based research networks. The consultation between patient and physician will be audio-taped and transcribed. Following the consultation, patients and physicians will complete a set of questionnaires based on the EXACKTE2 model. All questionnaires will be similar for patients and physicians. These questionnaires will assess the key concepts of our proposed model based on the essential elements of shared decision-making (SDM): definition and explanation of problem; presentation of options; discussion of pros and cons; clarification of patient values and preferences; discussion of patient ability and self-efficacy; presentation of doctor knowledge and recommendation; and checking and clarifying understanding. Patients will be contacted by phone two weeks later and asked to complete questionnaires on decisional regret and quality of life. The analysis will be conducted to compare the key concepts in the EXACKTE2 model between patients and physicians. It will also allow the assessment of how patients and physicians influence each other in consultations.</p>
<p>Discussion: Our proposed model, EXACKTE2, is aimed at advancing the science of KTE based on a relationship process when decision-making has to take place. It fosters a new KTE paradigm by putting forward a relationship-centered perspective and has the potential to reveal unknown mechanisms that underline effective KTE in clinical contexts. This will result in better understanding of the mechanisms that may promote a new generation of knowledge transfer strategies.</p>

	]]>
</description>

<author>France Légaré et al.</author>


</item>





</channel>
</rss>
